Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | 66,767 | reported | 02 May 2024 | tx 226+879,141−615,981 |
| Viridian Therapeutics, Inc.\DE | 21,000 | reported | 01 Jul 2025 | tx 2+63,000 |
| NEKTAR THERAPEUTICS | 8,000 | reported | 30 Sept 2025 | tx 27+441,300−29,097 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Sept 2025 | GRANT_AWARD | NEKTAR THERAPEUTICS | 8,000 | 0.00 USD | deriv |
| 01 Jul 2025 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 21,000 | 0.00 USD | deriv |
| 07 Apr 2025 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 42,000 | 0.00 USD | deriv |
| 18 Sept 2024 | GRANT_AWARD | NEKTAR THERAPEUTICS | 120,000 | 0.00 USD | deriv |
| 30 Apr 2024 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 300 | 68.65 USD | |
| 02 May 2024 | SALE | BIOMARIN PHARMACEUTICAL INC | 5,000 | 82.91 USD | |
| 15 Mar 2024 | TAX_WITHHOLDING | BIOMARIN PHARMACEUTICAL INC | 22,580 | 83.87 USD | |
| 05 Mar 2024 | SALE | BIOMARIN PHARMACEUTICAL INC | 4,000 | 87.07 USD | |
| 27 Feb 2024 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 9,338 | 0.00 USD | |
| 27 Feb 2024 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 6,465 | 0.00 USD | |
| 27 Feb 2024 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 21,440 | 0.00 USD | |
| 18 Sept 2023 | SALE | NEKTAR THERAPEUTICS | 4,359 | 0.69 USD | |
| 19 Sept 2023 | GRANT_AWARD | NEKTAR THERAPEUTICS | 85,000 | 0.00 USD | deriv |
| 16 Aug 2023 | SALE | BIOMARIN PHARMACEUTICAL INC | 5,000 | 90.00 USD | |
| 28 Apr 2023 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 318 | 66.88 USD | |
| 15 Mar 2023 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 10,110 | 0.00 USD | |
| 15 Mar 2023 | TAX_WITHHOLDING | BIOMARIN PHARMACEUTICAL INC | 3,971 | 87.74 USD | |
| 16 Mar 2023 | TAX_WITHHOLDING | BIOMARIN PHARMACEUTICAL INC | 20,510 | 93.41 USD | |
| 15 Mar 2023 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 23,070 | 0.00 USD | deriv |
| 28 Feb 2023 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 20,760 | 0.00 USD | |
| 28 Feb 2023 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 10,380 | 0.00 USD | |
| 28 Feb 2023 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 7,629 | 0.00 USD | |
| 25 Jan 2023 | SALE | BIOMARIN PHARMACEUTICAL INC | 4,175 | 116.15 USD | |
| 25 Jan 2023 | SALE | BIOMARIN PHARMACEUTICAL INC | 44,825 | 115.65 USD | |
| 25 Jan 2023 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 49,000 | 67.81 USD |